MENLO THERAPEUTICS INC's ticker is MNLO and the CUSIP is 586858102. A total of 59 filers reported holding MENLO THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $411,000 | +211.4% | 237,750 | +381.9% | 0.00% | +100.0% |
| Q1 2020 | $132,000 | -50.2% | 49,337 | -13.7% | 0.00% | -33.3% |
| Q4 2019 | $265,000 | -18.2% | 57,202 | -21.0% | 0.00% | -25.0% |
| Q3 2019 | $324,000 | -52.6% | 72,396 | -36.6% | 0.00% | -55.6% |
| Q2 2019 | $684,000 | -16.9% | 114,109 | +8.8% | 0.01% | -25.0% |
| Q1 2019 | $823,000 | +106.3% | 104,893 | +8.4% | 0.01% | +71.4% |
| Q4 2018 | $399,000 | – | 96,793 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DSC Advisors, L.P. | 4,359,030 | $7,541,000 | 8.27% |
| Healthcare Value Capital, LLC | 1,700,000 | $2,941,000 | 7.51% |
| 683 Capital Management, LLC | 5,550,208 | $9,602,000 | 0.77% |
| Perceptive Advisors | 22,876,410 | $39,576,000 | 0.64% |
| Vivo Capital, LLC | 3,643,824 | $6,304,000 | 0.45% |
| Monashee Investment Management LLC | 1,005,000 | $1,739,000 | 0.26% |
| MYDA Advisors LLC | 93,300 | $161,000 | 0.10% |
| Sofinnova Investments, Inc. | 725,571 | $1,256,000 | 0.08% |
| CAAS CAPITAL MANAGEMENT LP | 1,185,501 | $2,051,000 | 0.07% |
| Grace Capital | 36,012 | $62,000 | 0.05% |